EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 308 filers reported holding EXELIXIS INC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,995 | +27.4% | 2,009 | +5.2% | 0.00% | 0.0% |
| Q4 2022 | $30,620 | -28.8% | 1,909 | -19.1% | 0.00% | 0.0% |
| Q2 2021 | $43,000 | -8.5% | 2,360 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $47,000 | +113.6% | 2,360 | +164.0% | 0.00% | +100.0% |
| Q3 2020 | $22,000 | +69.2% | 894 | +17.6% | 0.00% | 0.0% |
| Q1 2020 | $13,000 | +62.5% | 760 | +60.0% | 0.00% | – |
| Q4 2019 | $8,000 | -94.3% | 475 | -92.8% | 0.00% | -100.0% |
| Q3 2019 | $141,000 | 0.0% | 6,585 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $141,000 | -47.6% | 6,585 | -41.8% | 0.01% | -52.6% |
| Q1 2019 | $269,000 | +43.9% | 11,310 | +18.9% | 0.02% | +18.8% |
| Q4 2018 | $187,000 | +2237.5% | 9,515 | +1903.2% | 0.02% | +1500.0% |
| Q3 2018 | $8,000 | -20.0% | 475 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $10,000 | – | 475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |